Objective: Neutrophil transendothelial migration, a key feature of skeletal
muscle ischemia and reperfusion (I/R) injury, is mediated by the platelet
endothelial cell adhesion molecule-1 (PECAM-1). Peroxynitrite anion, a toxi
c product of neutrophil superoxide anion and nitric oxide, contributes to o
xidative skeletal muscle injury and can be quantified by measurement of pro
tein tyrosine nitration after I/R. This study hypothesizes that administrat
ion of the PECAM-1/IgG antibody chimera will inhibit peroxynitrite-mediated
injury after I/R.
Methods: The study was composed of five groups: an I/R group (n = 4), a sha
m treatment group anesthetic control (n = 3), a treatment group receiving t
he PECAM-1/immunoglobulin G (IgG) antibody chimera with I/R (n = 9), a trea
tment group receiving human IgG with I/R as an antibody control (n = 6), an
d a treatment group receiving normal saline solution with I/R as a vehicle
control (n = 5). The right hind limb in mate New Zealand white rabbits was
rendered ischemic by occluding the iliac and femoral arteries for 3 hours,
followed by 2 hours of reperfusion (I/R). Sham-treated rabbits underwent ar
terial dissection without arterial occlusion. PECAM-1/IgG-treated rabbits a
nd IgG-treated rabbits received an infusion of 1 mg/kg in normal saline sol
ution 20 mL via an ear vein catheter during the last 5 minutes of ischemia
and the first 15 minutes of reperfusion. Saline solution-treated rabbits si
milarly received normal saline solution 20 mL. The anterior tibialis muscle
was harvested after reperfusion. Immunohistochemical staining for nitrotyr
osine was performed with monoclonal antinitrotyrosine antibodies and fluore
scently labeled secondary antibodies. Computed morphometric study was perfo
rmed to calculate relative fluorescence scores for each histologic section.
Averaged fluorescence scores were analyzed by one-way analysis of variance
with Bonferroni post hoc comparison.
Results: The averaged fluorescence scores (mean +/- SEM) for the sham-treat
ed (2.88 +/- 0.78) and PECAM-1/IgG-treated (6.16 +/- 0.43) groups demonstra
ted a significant reduction in quantitative fluorescence compared with the
IgG- (15.17 +/- 2.01) and saline solution-treated (17.46 +/- 3.71) control
groups, and the I/R-treated (18.52 +/- 3.00) group, (P < .05).
Conclusions: These results suggest that PECAM-1/IgG diminishes peroxynitrit
e-mediated oxidative skeletal muscle injury by inhibiting neutrophil transe
ndothelial migration and may therefore prove a useful therapeutic agent in
the treatment of reperfusion injury.